Proviral load and the balance of serum cytocines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Acta Tropica

Volumn 125, Issue 1, 2013, Pages 75-81

  Starling, Ana Lúcia Borges ^a   Martins Filho, Olindo Assis ^b   Lambertucci, José Roberto ^a   Labanca, Ludimila ^a   de Souza Pereira, Silvio Roberto ^a   Teixeira Carvalho, Andréa ^b   Martins, Marina Lobato ^c   Ribas, João Gabriel ^d   Carneiro Proietti, Anna Bárbara F ^c,e   Gonçalves, Denise Utsch ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Serviço de Pesquisa Fundação Centro de Hematologia E Hemoterapia de Minas Gerais HEMOMINAS   (Brazil)

^d Hospital Sarah Kubitschek   (Brazil)

^e FASEH Faculdade da Saúde e Ecologia Humana   (Brazil)

Author keywords

Cytokine; HAM TSP; HTLV 1; Proviral load

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

BLOOD; CONCENTRATION (COMPOSITION); CORRELATION; PLASMA; SERUM; VIRAL DISEASE;

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; BRAZIL; CONTROLLED STUDY; DISEASE CARRIER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; SEROLOGY; TROPICAL SPASTIC PARAPARESIS; VIROLOGY; VIRUS LOAD; WESTERN BLOTTING;

ADULT; AGED; ASYMPTOMATIC INFECTIONS; CYTOKINES; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; PROVIRUSES; SERUM; VIRAL LOAD; YOUNG ADULT;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84868699918     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2012.09.012     Document Type: Article

References (35)

1. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 1990, 4:2860-2867.
2. Asquith B., Bangham C.R. The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection. Journal of Theoretical Biology 2000, 207:65-79.
3. Biddison W.E., Kubota R., Kawanishi T., Taub D.D., Cruikshank W.W., Center D.M., Connor E.W., Utz U., Jacobson S. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. Journal of Immunology 1997, 159:2018-2025.
4. Brito-Melo G.E., Peruhype-Magalhaes V., Teixeira-Carvalho A., Barbosa-Stancioli E.F., Carneiro-Proietti A.B., Catalan-Soares B., Ribas J.G., Martins-Filho O.A. IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection. Clinical and Experimental Immunology 2007, 147:35-44.
5. Camporeale A., Poli V. IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?. Frontiers in Bioscience 2012, 17:2306-2326.
6. Carvalho E.M., Bacellar O., Porto A.F., Braga S., Galvao-Castro B., Neva F. Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. Journal of Acquired Immune Deficiency Syndromes 2001, 27:1-6.
7. Chen R., Lowe L., Wilson J.D., Crowther E., Tzeggai K., Bishop J.E., Varro R. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clinical Chemistry 1999, 45:1693-1694.
8. De Castro-Costa C.M., Araujo A.Q., Barreto M.M., Takayanagui O.M., Sohler M.P., da Silva E.L., de Paula S.M., Ishak R., Ribas J.G., Rovirosa L.C., Carton H., Gotuzzo E., Hall W.W., Montano S., Murphy E.L., Oger J., Remondegui C., Taylor G.P. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Research and Human Retroviruses 2006, 22:931-935.
9. Denys A., Udalova I.A., Smith C., Williams L.M., Ciesielski C.J., Campbell J., Andrews C., Kwaitkowski D., Foxwell B.M. Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. Journal of Immunology 2002, 168:4837-4845.
10. Goncalves D.U., Proietti F.A., Barbosa-Stancioli E.F., Martins M.L., Ribas J.G., Martins-Filho O.A., Teixeira-Carvalho A., Peruhype-Magalhaes V., Carneiro-Proietti A.B. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network. Inflammation & Allergy Drug Targets 2008, 7:98-107.
11. Goon P.K., Igakura T., Hanon E., Mosley A.J., Asquith B., Gould K.G., Taylor G.P., Weber J.N., Bangham C.R. High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-\reting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease. Journal of virology 2003, 77:9716-9722.
12. Goon P.K., Igakura T., Hanon E., Mosley A.J., Barfield A., Barnard A.L., Kaftantzi L., Tanaka Y., Taylor G.P., Weber J.N., Bangham C.R. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. Journal of Immunology 2004, 172:1735-1743.
13. Hanon E., Goon P., Taylor G.P., Hasegawa H., Tanaka Y., Weber J.N., Bangham C.R. High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood 2001, 98:721-726.
14. Hanon E., Hall S., Taylor G.P., Saito M., Davis R., Tanaka Y., Usuku K., Osame M., Weber J.N., Bangham C.R. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000, 95:1386-1392.
15. Jeffery K.J., Usuku K., Hall S.E., Matsumoto W., Taylor G.P., Procter J., Bunce M., Ogg G.S., Welsh K.I., Weber J.N., Lloyd A.L., Nowak M.A., Nagai M., Kodama D., Izumo S., Osame M., Bangham C.R. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:3848-3853.
16. Kaplan J.E., Osame M., Kubota H., Igata A., Nishitani H., Maeda Y., Khabbaz R.F., Janssen R.S. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. Journal of Acquired Immune Deficiency Syndromes 1990, 3:1096-1101.
17. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
18. Lal R.B., Rudolph D.L. Constitutive production of interleukin-6 and tumor necrosis factor-alpha from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/II. Blood 1991, 78:571-574.
19. Levin M.C., Jacobson S. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. Journal of Neurovirology 1997, 3:126-140.
20. Macchi B., Grelli S., Matteucci C., D'Elios M.M., De Carli M., Favalli C., Del Prete G., Mastino A. Human Th1 and Th2 T-cell clones are equally susceptible to infection and immortalization by human T-lymphotropic virus type I. The Journal of General Virology 1998, 79(Pt 10):2469-2474.
21. Manns A., Miley W.J., Wilks R.J., Morgan O.S., Hanchard B., Wharfe G., Cranston B., Maloney E., Welles S.L., Blattner W.A., Waters D. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. The Journal of Infectious Diseases 1999, 180:1487-1493.
22. Matsuzaki T., Nakagawa M., Nagai M., Usuku K., Higuchi I., Arimura K., Kubota H., Izumo S., Akiba S., Osame M. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. Journal of Neurovirology 2001, 7:228-234.
23. Muniz A.L., Rodrigues W., Santos S.B., de Jesus A.R., Porto A.F., Castro N., Oliveira-Filho J., Almeida J.P., Moreno-Carvalho O., Carvalho E.M. Association of cytokines, neurological disability, and disease duration in HAM/TSP patients. Arquivos De Neuro-Psiquiatria 2006, 64:217-221.
24. Nakamura S., Nagano I., Yoshioka M., Shimazaki S., Onodera J., Kogure K. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. Journal of Neuroimmunology 1993, 42:127-130.
25. Nishimoto N., Yoshizaki K., Eiraku N., Machigashira K., Tagoh H., Ogata A., Kuritani T., Osame M., Kishimoto T. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. Journal of the Neurological Sciences 1990, 97:183-193.
26. Nishiura Y., Nakamura T., Ichinose K., Shirabe S., Tsujino A., Goto H., Furuya T., Nagataki S. Increased production of inflammatory cytokines in cultured CD4+ cells from patients with HTLV-I-associated myelopathy. The Tohoku Journal of Experimental Medicine 1996, 179:227-233.
27. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Annals of Neurology 1987, 21:117-122.
28. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. Human Retrovirology: HTLV 1990, 191-197. Raven Inc., New-York. W.A. Blattner (Ed.).
29. Proietti F.A., Carneiro-Proietti A.B., Catalan-Soares B.C., Murphy E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24:6058-6068.
30. Sakai I., Yamauchi H., Yasukawa M., Kohno H., Fujita S. Expression of the Gfi-1 gene in HTLV-1-transformed T cells. International Journal of Hematology 2001, 73:507-516.
31. Takenouchi N., Yamano Y., Usuku K., Osame M., Izumo S. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. Journal of Neurovirology 2003, 9:29-35.
32. Taylor G.P., Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 2005, 24:6047-6057.
33. Umehara F., Izumo S., Nakagawa M., Ronquillo A.T., Takahashi K., Matsumuro K., Sato E., Osame M. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. Journal of Neuropathology and Experimental Neurology 1993, 52:424-430.
34. Villiger P.M., Cronin M.T., Amenomori T., Wachsman W., Lotz M. IL-6 production by human T lymphocytes Expression in HTLV-1-infected but not in normal T cells. Journal of Immunology 1991, 146:550-559.
35. Yamano Y., Nagai M., Brennan M., Mora C.A., Soldan S.S., Tomaru U., Takenouchi N., Izumo S., Osame M., Jacobson S. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002, 99:88-94.